Naturalistic observation of athletic drug-use patterns and behavior in professional-caliber bodybuilders

Substance Use and Misuse

Volumn 34, Issue 2, 1999, Pages 217-249

  Augé II, Wayne K ^a,c   Augé, Suzanne M ^b  

^a U States Dept Hlth and Hum Serv   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c NONE   (United States)

Author keywords

Athletes; Bodybuilding; Doping in sports; Naturalistic observation participant observer; Sports medicine

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANDROGEN; ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; SEX HORMONE; STEROID;

ARTICLE; ATHLETE; BODY BUILDING; CLINICAL ARTICLE; DOPING; DRUG ABUSE PATTERN; DRUG MISUSE; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; MEDICAL LITERATURE; PRIORITY JOURNAL; SPORT; TRAINING;

EID: 0032969885     PISSN: 10826084     EISSN: None     Source Type: Journal    
DOI: 10.3109/10826089909035644     Document Type: Article

References (96)

1. ACSM (American College of Sports Medicine) (1977). Position statement on the use and abuse of anabolic-androgenic steroids in sports. Med. Sci. Sports 9: 11-13.
2. ALBRECHT, R. R., ANDERSON, W. A., MCGREW, C. A., MCKEAG, D. B., and HOUGH, D. O. (1992). NCAA institutionally based drug testing: Do our athletes know the rules of the game? Med. Sci. Sports Exercise 24(2): 242-246.
3. ANSHER, M. H. (1991). Causes for drug abuse in sport: A survey of intercollegiate athletes. J. Sport Behav. 14(4): 283-307.
4. ANSHEL, M. H., and RUSSELL, K. G. (1997). Examining athletes' attitudes toward using anabolic steroids and their knowledge of the possible effects. J. Drug Educ. 29(2): 121-145.
5. AQUILINO, W. S. (1992). Telephone versus face-to-face interviewing for household drug use surveys. Int. J. Addict. 27(1): 71-91.
6. ARIEL, G., and SAVILLE, W. (1972). Anabolic steroids: The physiological effects of placebos. Med. Sci. Sports 4: 124-126.
7. AUGÉ II, W. K., and FISCHER, R. A. (1998). Arthroscopic distal clavicle resection for isolated atraumatic osteolysis in weight lifters. Am. J. Sports Med. 26(2): 189-192.
8. BAUMAN, D. H., RICHERSON, J. T., and BRITT, A. L. (1988). A comparison of body and organ weights, physiologic parameters, and pathologic changes in target organs of rats given combinations of exercise, anabolic hormone, and protein supplementation. Am. J. Sports Med. 16: 397-402.
9. BERENDONK, B. (1991). Doping: Von der Forschung bis zum Betrug. Berlin: Springer-Verlag.
10. BERESFORD, H. R. (1989). Legal considerations. In G. I. Wadler and B. Hainline (Eds.), Drugs and the Athlete. Philadelphia, PA: F. A. Davis Co., pp. 234-247.
11. BRILL, J. B., and KEANE, M. W. (1994). Supplementation patterns of competitive male and female bodybuilders. Int. J. Sport Nutr. 4(4): 398-412.
12. BUCKLEY, W. E., YESALIS III, C. E., FRIEDL, K. E., et al. (1988). Estimated prevalence of anabolic steroid use among male high school seniors. JAMA 260: 3441-3445.
13. CECCHI, R., and CIPOLLONI, L. (1992). Considerazioni in tema di doping 1993. Zacchia 66: 201-214: De Juliis T & Vittorioso V La Tutela Sanitaria delle Attività Sportive e la Lotta al Doping.
14. CHOU, C. P., HSER, Y. I., and ANGLIN, M. D. (1996). Pattern reliability of narcotics addicts' self-reported data: A confirmatory assessment of construct validity and consistency. Substance Use Misuse 31(9): 1189-216.
15. CND ANALYTICAL (1989). Analytical Profiles of Anabolic Steroids. Auburn, AL, p. 5.
16. COLEMAN, P. D., A'HEARN, E., TAYLOR, R. W., and LE, S. D. (1991). Anabolic steroids - Analysis of dosage forms from selected case studies from the Los Angeles County Sheriff's Scientific Services Bureau. J. Forensic Sci. 36(4): 1079-1088.
17. COOPER, C. J., NOAKES, T. D., DUNNE, T., LAMBERT, M. I., and ROCHFORD, K. (1996). A high prevalence of abnormal personality traits in chronic users of anabolic-androgenic steroids. Br. J. Sports Med. 30(3): 246-250.
18. COOPER, D. L. (1972). Drugs and the athlete. JAMA 221: 1007-1011.
19. COX, J. S. (1990). Presidential address of the American Orthopedic Society for Sports Medicine. Drug abuse in sports. Am. J. Sports Med. 18(6): 568-572.
20. DEUTSCHE PRESSEAGEUTUR (1997). Schwimmerinnen in der nühe der fabelrekorde. Schon wieder spekulationen um Chinas schwimmerin. Süddeutsche Zeitung, January 11.
21. DEZELSKY, T. L., TOOHEY, J. V., and SHAW, R. S. (1985). Non-medical drug use behavior at five United States universities: A 15 year study. Bull. Narc. 37: 49-53.
22. DICKHUTH, H. H., BERG, A., BAUMSTARK, M., ROKITZKI, L., HUONKER, M., and KEUL, J. (1989). [Doping - Also a problem in general practice?]. Fortschr. Med. 107(28): 585-588.
23. DISHMAN, R. K. (1985). Medical psychology in exercise and sport. Med. Clin. North Am. 69: 123.
24. DURANT, R. H., ASHWORTH, C. S., NEWMAN, C., and RICKERT, V. I. (1994). Stability of the relationships between anabolic steroid use and multiple substance use among adolescents. J. Adolesc. Health 15(2): 111-116.
25. DURANT, R. H., ESCOBEDO, L. G., and HEATH, G. W. (1995). Anabolic-steroid use, strength training, and multiple drug use among adolescents in the United States. Pediatrics 96(1): 23-28.
26. EGGINTON, S. (1987). Effects of an anabolic hormone on striated muscle growth and performance. Pflügers Arch. 410: 349-355.
27. EICHNER, E. R. (1997). Ergogenic aids: What athletes are using and why. Physician Sports Med. 25(4): 70-83.
28. ENGLISH, G. (1987). A theoretical explanation of why athletes choose to use steroids and the role of the coach in influencing behavior. Natl. Strength Conditioning Assoc. J. 9(1): 53-56.
29. FAHEY, T., and BROWN, H. (1972). Effects of anabolic steroids plus weight training on normal males - A double blind study. Med. Sci. Sports 4: 54-59.
30. FEILDS, L., LANGE, W. R., KREITER, N. A., and FUDALA, P. J. (1994). A national survey of drug testing policies for college athletes. Med. Sci. Sports Exercise 26(6): 682-686.
31. FELTZ, D. L., and EWING, M. E. (1987). Psychological characteristics of elite young athletes. Med. Sci. Sports Exercise 19: S98.
32. FOWLER, W. M., GARDNER, G. W., and EGSTROM, G. H. (1965). Effect of an anabolic steroid on physical performance of young men. J. Appl. Physiol. 20: 1038-1040.
33. FRANKE, W. W., and BERENDONK, B. (1997). Hormonal doping and androgenization of athletes: A secret program of the German Democratic Republic government. Clin. Chem. 43(7): 1262-1279.
34. FRANKLE, M. A., CICERO, G. J., and PAYNE, J. (1984). Use of androgenic anabolic steroids by athletes. JAMA 252: 482-489.
35. FULLER, J. R., and LAFOUNTAIN, M. J. (1987). Performance-enhancing drugs in sport: A different form of drug abuse. Adolescents 22(88): 969-976.
36. GOLDBERG, L., ELLIOT, D., CLARKE, G. N., MACKINNON, D. P., et al. (1996). Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program. JAMA 276(19): 1555-1562.
37. GRIGGS, R. C., KINGSTON, W., JOZEFOWICZ, R. F., HERR, B. E., FORBES, G., and HALLIDAY, D. (1989). Effect of testosterone on muscle mass and muscle protein synthesis. J. Appl. Physiol. 66: 498-503.
38. HÄCKER, R., and DEMARÉES, H. (1991). Hormonelle regulation undpsychophysische belastung im leistungssport. Kölin: Deutscher Ärzte-Verlag.
39. HARRISON, L. D., and KENNEDY, N. J. (1996). Drug use in the high intensity drug trafficking area of the US southwest border. Addiction 91(1): 47-61.
40. HAUPT, H. A. (1989). Drugs in athletics. Clin. Sports Med. 8: 561-582.
41. HAUPT, H. A. (1993). Current concepts. Anabolic steroids and growth hormone. Am. J. Sports Med. 21: 468-474.
42. HAUPT, H. A., and ROVERE, G. D. (1984). Anabolic steroids: A review of the literature. Am. J. Sports Med. 12: 469-484.
43. HEATH, D. B. (1990). Cultural factors in the choice of drugs. Recent Dev. Alcohol 8: 245-254.
44. HECHT, R. W., MCKEEVER, K. H., ALWAY, S. E., AUGÉ II, W. K., BERTONE, A. L., and LOMBARDO, J. A. (1996). Resistance training-induced increases in muscle mass and performance in ponies. Med. Sci. Sports Exercise 28(7): 877-883.
45. HEITHOFF, K. A., and WISEMAN, E. J. (1996). Reliability of paper-pencil assessment of drug use severity. Am. J. Drug Alcohol Abuse 22(1): 109-122.
46. HICKSON, J. F., JOHNSON, T. E., LEE, W., and SIDOR, R. J. (1990). Nutrition and the precontest preparations of a male bodybuilder. J. Am. Diet Assoc. 90(2): 264-267.
47. IFBB (International Federation of Bodybuilders) (1996). Judges' Guidebook.
48. IFBB (International Federation of Bodybuilders) (1997) Personal communication: Professional Division.
49. IOC (1988). International Olympic Charter Against Doping in Sport. As drafted at the First Permanent World Conference on Antidoping in Sports, Ottawa, Canada, June 26-29.
50. JOHNSON, J., and WILLIAMS, M. L. (1993). A preliminary ethnographic decision tree model of injection drug users' needle sharing. Int. J. Addict. 28(10): 997-1014.
51. JONES, R. T. (1992). Alternative strategies. Ciba Found. Symp. 166: 224-241.
52. KAMBER, M. (1990). [The fight against doping: International and national efforts as exemplified by the Convention of the Council of Europe and the doping regulations of the Swiss National Association for Sports]. Schweiz. Z. Sportmed. 38(2): 101-106.
53. KOURI, E. M., POPE, H. G., KATZ, D. L., and OLIVA, P. (1995). Fat-free mass index in users and nonusers of anabolic steroids. Clin. J. Sport Med. 5(4): 223-228.
54. LALLI, J. S., and GOH, H. L. (1993). Naturalistic observations in community settings. In Communicative Alternatives to Challenging Behavior: Integrating Functional Assessment and Intervention. Baltimore, MD: P.H. Brooks Publishing Co., pp. 11-39.
55. LAMB, D. R. (1984). Anabolic steroids in athletics: How well do they work and how dangerous are they? Am. J. Sports Med. 12: 31-38.
56. LURIE, I. S., SOERLING, A. R., and MEYERS, R. P. (1984). The determination of anabolic steroids by MECC, gradient HPLC, and capillary GC. J. Forensic Sci. 39(1): 74-85.
57. MAGURA, S., and KANG, S. Y. (1996). Validity of self-reported drug use in high risk populations: A meta-analytical review. Substance Use Misuse 31 (9): 1131-1153.
58. MCALLISTER, I., and MAKKAI, T. (1991). Correcting for the underreporting of drug use in opinion surveys. Int. J. Addict. 26(9): 945-961.
59. MCCAULEY, E. (1987). Sport psychology in the eighties: Some current developments. Med. Sci. Sports Exercise 19: S95.
60. MCGOVERN, M. P. (1982). Alcoholism in southeast Asia. Prevalence and treatment. Int. J. Soc. Psychiatry 28(1): 36-44.
61. MEILMAN, P W., CRACE, R. K., PRESLEY, C. A., and LYERLA, R. (1995). Beyond performance enhancement: Polypharmacy among collegiate users of steroids. J. Am. Coll. Health 44(3): 98-104.
62. NEWMAN, M. (1986). Michigan Consortium of Schools Student Survey. Minneapolis, MN: Hazelden Research Services.
63. OSEID, S. (1977). How can we prevent and control the use and misuse of anabolic steroids in international sports? Br. J. Sports Med. 11(4): 174-175.
64. PARROT, A. C., CHOI, P. Y., and DAVIES, M. (1994). Anabolic steroid use by amateur athletes: Effects upon psychological mood states. J. Sports Med. Phys. Fitness 34(3): 292-298.
65. PERRY, P. J., ANDERSEN, K. H., and YATES, W. R. (1990). Illicit anabolic steroid use in athletes. A case series analysis. Am. J. Sports Med. 18: 422-428.
66. PLANT, M. A., and REEVES, C. E. (1976). Participant observation as a method of collecting information about drug taking: Conclusions from two English studies. Br. J. Addict. 71(2): 155-159.
67. POULIN, C., MACNEIL, P., and MITIC, W. (1993). The validity of a province-wide student drug use survey: Lessons in design. Can. J. Public Health 84(4): 259-264.
68. POWER, R. (1989). Participant observation and its place in the study of illicit drug abuse. Br. J. Addict. 84(1): 43-52.
69. POWIS, B., GRIFFITHS, P., GOSSOP, M., and STRANG, J. (1996). The differences between male and female drug users: Community samples of heroin and cocaine. Substance Use Misuse 31(5): 529-543.
70. RȦCZ, J. G. (1992). Drug use by the members of youth subcultures in Hungary. Int. J. Addict. 27(3): 289-300.
71. ROGOZKIN, V. (1979). Metabolic effects of anabolic steroid on skeletal muscle. Med. Sci. Sports 11: 160-163.
72. ROOM, R., JANCA, A., BENNETT, L. A., SCHMIDT, L., and SARTORIUS, N. (1996). WHO cross-cultural applicability research on diagnosis and assessment of substance use disorders: An overview of methods and selected results. Addiction 91(2): 199-230.
73. ROSENBERG, K. M., and DALEY, H. B. (1993). Origins and interpretations of data. In Foundations of Behavioral Research: A Basic Question Approach. New York, NY: Harcourt Brace Jovanovich, College Publishers, pp. 39-61.
74. RYAN, A. J. (1983). Bodybuilding: Exercise and sport. Physician Sports Med. 11(5): 39-43.
75. SEGURA, J. (1996). Doping control in sports medicine. Ther. Drug Monit. 18(4): 471-476.
76. SEIIFULLA, R. D. (1994). [The use of drugs by the healthy human being]. Eksp. Klin. Farmakoter. 57(3): 3-6.
77. SMEJA, C. M., and ROJEK, D. G. (1986). Youthful drug use and drug subcultures. Int. J. Addict. 21(9-10): 1031-1050.
78. SMITH, D. A. and PERRY, P. J. (1992). The efficacy of ergogenic agents in athletic competition. Part I: Androgenic-anabolic steroids. Ann. Pharmacother. 26(4): 520-528.
79. STEEN, S. N. (1991). Precontest strategies of a male bodybuilder. Int. J. Sport Nutr. 1(1): 69-78.
80. STROBEL, E. (1988). [Pregnancy as a doping measure? Dangerous development in high performance sports]. Fortschr. Med. 106(29):14.
81. STROMME, S. B., MEEN, H. D., and AAKVAAG, A. (1974). Effects of an androgenic-anabolic steroid on strength development and plasma testosterone levels in normal males. Med. Sci. Sports 6: 203-208.
82. SUSSMAN, S., HAHN, G., DENT, C. W., STACY, A. W., et al. (1993). Naturalistic observation of adolescent tobacco use. Int. J. Addict. 28(9): 803-811.
83. TOBLER, N. (1986). Meta-analyses of 143 adolescent drug prevention programs: Quantitative outcome results of program participants compared to a control or comparison group. J. Drug Issues 16(4): 537-567.
84. TRICKER, R., and CONNOLLY, D. (1997). Drugs and the college athlete: An analysis of the attitudes of student athletes at risk. J. Drug Educ. 27(2): 105-119.
85. TRICKER, R., O'NEILL, M. R., and COOK, D. (1989). The incidence of anabolic steroid use among competitive bodybuilders. J. Drug Educ. 19(4): 313-325.
86. VAN DER MERWE, P. J., and KRUGER, H. S. (1992). Drugs in sport - Results of the past six years of dope testing in South Africa. S. Afr. Med. J. 82(3): 151-153.
87. VIRVIDAKIS, K., SIDERAS, G., and PAPADAKIS, E. (1987). Effect of doping control on weight lifting performance. Int. J. Sports Med. 8(6): 397-400.
88. VOY, R. (1991). Drugs, Sport, and Politics. Champaign, IL: Leisure Press.
89. WADE, N. (1972). Anabolic steroids: Doctors denounce them, but athletes aren't listening. Science 176: 1399-1403.
90. WADLER, G. I., and HAINLINE, B. (1989). In A. J. Ryan (Ed.), Drugs and the Athlete (Contemporary Exercise and Sport Medicine Series). Philadelphia, PA: F. A. Davis Co., pp. 3-17.
91. WEINFURT, K. P., and BUSH, P. J. (1996). Contradictory subject response in longitudinal research. J. Stud. Alcohol 57(3): 273-282.
92. WILLIAMSON, D. J. (1993). Anabolic steroid use among students at a British college of technology. Br. J. Sports Med. 27(3): 200-201.
93. WILMONT, R. (1979). Participant observation: A methodological approach to the study of halfway houses for alcoholics. Br. J. Addict. 74(4): 369-375.
94. WILSON, J. D., and GRIFFIN, J. E. (1980). The use and misuse of androgens. Metabolism 29: 1278-1295.
95. WRIGHT, J. E. (1980). Anabolic steroids and athletics. Exercise Sport Sci. 8: 149-202.
96. YESALIS, C. E., STREIT, A. L., VICARY, J. R., et al. (1989a). Anabolic steroid use: Indications and habituation among adolescents. J. Drug Educ. 19: 103-116.